Premenstrual syndrome affects up to 80% of menstruating women to some degree, according to the Royal College of Obstetricians and Gynaecologists (RCOG). For most, symptoms are mild and manageable. But for approximately 5–8% of women, PMS is severe enough to significantly impair daily functioning — and a smaller subset meet the criteria for premenstrual dysphoric disorder (PMDD), a condition recognised in the DSM-5 that carries serious mental health implications.

Community pharmacists, positioned as the most accessible healthcare professionals in the UK, are frequently the first point of contact for women seeking help with premenstrual symptoms. The renewed Women's Health Strategy, published in April 2026, reinforces the importance of listening to women and ensuring their health concerns are taken seriously across all healthcare settings.

Common PMS symptoms

PMS encompasses a wide range of physical and psychological symptoms that occur in the luteal phase (the two weeks before menstruation) and resolve within a few days of the period starting:

Physical: breast tenderness, bloating, headache, fatigue, weight gain from fluid retention, acne flare-ups, musculoskeletal pain

Psychological: irritability, mood swings, anxiety, low mood, difficulty concentrating, changes in appetite, sleep disturbance

The cyclical pattern is diagnostically important — symptoms that persist throughout the month are unlikely to be PMS and may indicate an underlying mood disorder, thyroid dysfunction or other condition.

OTC treatment options

Pharmacists can recommend several evidence-based approaches:

NSAIDs for physical symptoms

Ibuprofen (200–400mg up to three times daily) or naproxen (250mg twice daily, where available OTC for period-related pain) are effective for headache, breast tenderness and musculoskeletal discomfort. Timing matters: beginning NSAID therapy one to two days before symptoms typically start is more effective than waiting for symptoms to become established.

Vitamin B6 (pyridoxine)

NICE and RCOG guidelines acknowledge limited evidence that vitamin B6 at doses of 50–100mg daily may reduce PMS symptoms, particularly mood-related complaints. Pharmacists should advise:

• Do not exceed 100mg daily — chronic doses above 200mg are associated with peripheral neuropathy
• Allow two to three menstrual cycles to assess effectiveness
• Evidence quality is low; benefit may be modest

Magnesium

Some evidence suggests magnesium supplementation (200–400mg daily) may improve PMS-related bloating, fluid retention and mood symptoms. A 2010 review in the Journal of Women's Health found a small but statistically significant benefit. Magnesium glycinate or citrate forms are generally better tolerated than magnesium oxide.

Evening primrose oil

Despite its widespread use, evidence for evening primrose oil in PMS is weak. A 2009 Cochrane-style systematic review found no convincing benefit over placebo for PMS symptoms. Pharmacists should communicate this honestly: "Some women find it helpful, but clinical trials have not shown a clear benefit over placebo."

Calcium

A 2017 meta-analysis in Obstetrics & Gynecology found that calcium supplementation (1,000–1,200mg daily) reduced the overall severity of PMS symptoms. This is one of the better-evidenced supplement options for PMS.

Lifestyle advice

Pharmacists can supplement product recommendations with practical lifestyle guidance:

• Regular exercise — aerobic activity three to five times weekly has consistent evidence for reducing PMS symptoms, likely through endorphin release and stress reduction
• Reduce caffeine and alcohol — both can worsen breast tenderness, anxiety and sleep disturbance in the luteal phase
• Regular meals with complex carbohydrates — blood sugar stability may reduce mood swings
• Sleep hygiene — PMS-related sleep disturbance is common; standard sleep hygiene advice applies

When to refer: recognising PMDD

Premenstrual dysphoric disorder is a severe form of PMS affecting approximately 3–5% of menstruating women. It is not simply "bad PMS" — PMDD involves disabling psychological symptoms that significantly impair relationships, work and daily functioning.

Referral to a GP is appropriate when:

• Mood symptoms (severe depression, anxiety, emotional lability, anger) dominate the clinical picture
• Symptoms are so severe that they impair the ability to work, study or maintain relationships
• The patient reports suicidal ideation or self-harm in the premenstrual phase
• OTC measures and lifestyle changes have been tried for three or more cycles without adequate relief
• The patient requests hormonal treatment (combined pill, continuous progestogen) or SSRI therapy

NICE guidance notes that low-dose SSRIs (fluoxetine, sertraline) taken either continuously or only during the luteal phase are effective for PMDD — but this is a prescriber decision, not a pharmacy one.

The pharmacy's role

With over 13,000 community pharmacies across England and 1,742 active pharmacy vacancies reflecting ongoing workforce demand, community pharmacy remains the most accessible healthcare setting for millions of women. A five-minute conversation at the counter — asking about symptom patterns, reviewing what has been tried, and recommending evidence-based options — can make a genuine difference to quality of life.

The Women's Health Strategy asks that women be better heard. For PMS and PMDD, being heard starts with a pharmacist who takes the symptoms seriously, offers honest advice about what works and what does not, and knows when to refer.

Sources

• RCOG Green-top Guideline No. 48: Management of Premenstrual Syndrome
• NICE Clinical Knowledge Summary: Premenstrual syndrome
• Department of Health and Social Care, Women's Health Strategy renewal (April 2026)
• PharmSee pharmacy and vacancy data, accessed April 2026

Compare pharmacy services and explore salary data at PharmSee Salary Guide and Pharmacy Search.